---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-22-000008"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2022-02-03T23:59:59+00:00"
generated_at: "2026-06-27T11:23:39.342484+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics Q4 revenue down 8.6%, FY record $10.8B; raises dividend 6.5%; FY2022 guide adj EPS $8.65-$9.35

## Summary
- Fourth quarter revenues $2.74B (-8.6% YoY); diluted EPS $3.12 reported, $3.33 adjusted (-25.7% adj.).
- Full year 2021 revenues $10.79B (+14.3%); diluted EPS $15.55 reported, $14.24 adjusted (+27.4% adj.).
- Board increased quarterly dividend 6.5% to $0.66/share, payable April 20, 2022, record April 6, 2022.
- FY2022 guidance: revenues $9.0-$9.5B, adj. diluted EPS $8.65-$9.35; base business revenue growth 3.5%-6.0%.
- Cash from operations FY2021 $2.23B (+11.4% YoY); FY2022 cash from operations guided at least $1.6B.

## SEC filing metadata
- accession: 0001022079-22-000008
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2022-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000008/0001022079-22-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000008/dgx-20220203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-22-000008
- JSON: https://secwatch.observer/filing/0001022079-22-000008.json
- Plain text: https://secwatch.observer/filing/0001022079-22-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.